A
$ Value
$0
Shares
180,000
Price
$0
Filed
Jan 30
Insider
Name
Rubinstein Mark Lawrence
Title
Chief Medical Officer
CIK
0002103809
Roles
Officer
Transaction Details
Transaction Date
2026-01-28
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
180,000
Footnotes
The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Filing Info
Rubinstein Mark Lawrence's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-28 | ACHV | A | $0 |
Other Insiders at ACHV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Oki Mark K
Chief Financial Officer
|
— | — | 2026-01-28 |
|
Stewart Richard Alistair
Chief Executive Officer
|
— | — | 2026-01-28 |
|
Goldberg Andrew D.
CEO and President
|
— | — | 2026-04-18 |
|
Wan Jerry
Principal Accounting Officer
|
— | — | 2026-01-28 |
|
Xinos Jaime
Chief Commercial Officer
|
— | — | 2026-01-28 |
|
Donnelly Craig
Chief Operations Officer
|
— | — | 2026-01-28 |